Will You Be a Hero for the Cure?
May 11, 2011
Men’s health lecture in New York on May 24
May 11, 2011

HIV and nanotechnology: Workshop report i-base.info

Given the potential advantage of providing reduced toxicity, more durable formulations with improved pharmacokinetics (ie targeting macrophages to increase concentrations in lymph tissue and dramatically extending half-life and dosing intervals) and at a reduced cost makes it frustrating that so far none of these formulations has yet progressed to human studies.

A must read!

http://i-base.info/htb/14934

Nelson Vergel
Nelson Vergel
Chemical engineer, 34+ year HIV and cancer survivor, health author and educator . Founder of DiscountedLabs.com , ExcelMale.com , and PowerUSA.org

Comments are closed.